Global Infection Surveillance Solution Market - Strategic Insights and Forecasts (2025-2030)

The Global Infection Surveillance Solution Market is expected to attain US$1,185.741 million in 2030, growing at a CAGR of 7.84% during the forecast period, from US$813.029 million in 2025.

The global infection surveillance solution market is currently witnessing a structural expansion as rising patient acuity and inadequate nurse-to-patient staffing ratios force a requirement for automated safety oversight. Healthcare systems are successfully enlisting specialized software to mitigate the clinical burden of HAIs, which currently affect 7% of patients in high-income countries and 15% in low-income regions. This transition is becoming critical as the NHS England mandate currently forces 70% of trusts to reach core digitization standards by March 2026, creating an urgent infrastructure floor for surveillance tools. Regulatory influence is currently mounting through the WHO's IPC global strategies, which emphasize that well-implemented digital programs successfully reduce infection rates by up to 70%. Consequently, the industry is reaching a structural outcome where integrated surveillance is becoming a mechanical necessity for hospitals attempting to avoid financial penalties and improve public trust.

Market Dynamics

Drivers

• Prevalence of HAIs: With millions of patients affected globally each year, health systems are currently enlisting automated solutions to track multidrug-resistant pathogens.

• National Digitization Goals: The NHS 10-Year Health Plan is currently forcing the expansion of AI-powered features and single patient records to modernize secondary care.

• Shift to Value-Based Care: Payers and providers are successfully enlisting clinical decision support tools to maximize patient outcomes and reduce the length of hospital stays.

• Enhanced Diagnostic Accuracy: Clinical teams are currently enlisting expanded testing capabilities, such as BD's Vacutainer® Urine Complete Kit, to improve specimen quality for infection screening.

Restraints and Opportunities

• Cyber Security Vulnerabilities: Increasing reliance on digital health infrastructure is currently forcing a requirement for robust risk assessments to minimize the impact of severer cyber incidents.

• Data Management Complexity: Improper data handling and fragmented systems are currently constraining the ability of hospitals to maintain a unified surveillance front.

• Outpatient Clinic Expansion (Opportunity): Growth in ambulatory surgery centers is currently creating a requirement for lightweight, web-based surveillance platforms.

• Predictive Outbreak Detection (Opportunity): Enterprises are successfully enlisting predictive analytics to identify emerging threats via EHR and environmental data monitoring.

Supply Chain Analysis

The infection surveillance supply chain is currently transitioning from "isolated software vendors" to "integrated health-tech conglomerates" to provide holistic safety bundles. Major players are successfully enlisting strategic partnerships and spin-offs, evidenced by BD's 2026 combination of its Biosciences business with Waters Corporation, to sharpen their focus on core diagnostic solutions. This evolution is becoming critical as the market is reaching a structural outcome where the availability of real-time, connected data currently dictates the competitive advantage of surveillance providers.

Government Regulations

Key Developments

• BD Launches AI-Enabled Dispensing (April 2026): BD introduced an advanced medication dispensing system to the European market, successfully enlisting connected data to strengthen inventory and safety.

• Surgiphor™ 510(k) Clearance (March 2026): BD received FDA clearance for a 1000mL antimicrobial wound irrigation solution, currently enlisting a new standard for surgical safety.

• NHS AI Strategic Roadmap (Spring 2026): The UK government is currently enlisting an AI roadmap expected to define the integration of digital health advice and surveillance.

Market Segmentation

By Solution Type

Software continues to anchor the market, as hospitals enlist real-time analytics platforms. The Services segment is currently witnessing a rapid transition where providers enlist implementation and consulting to navigate complex EHR integrations. This movement is resulting in an outcome where Support and Maintenance are reaching a structural reliance on long-term service contracts to ensure system uptime.

By Deployment Mode

Cloud-based platforms are currently recorded as the high-growth segment, as they successfully enlist remote accessibility and lower upfront infrastructure costs for clinics. On-premise solutions are reaching a reliance on high-security environments and academic medical centers that prioritize localized data control. This shift is resulting in an outcome where "Web-Based" access is becoming the standard vehicle for small-scale healthcare providers.

By End-User

Hospitals currently represent the primary demand driver, as they successfully enlist large-scale digital health solutions to manage high-acuity patient volumes. Laboratories are currently witnessing a surge in automation, where they enlist integrated management systems to boost diagnostic accuracy. This movement is resulting in an outcome where Clinics are reaching a structural reliance on modular surveillance tools to maintain safety in outpatient settings.

Regional Analysis

North America currently maintains the largest market footprint, as advanced healthcare systems successfully enlist regulatory-driven infection prevention programs. Asia Pacific is currently recorded as the fastest-growing region, where countries like Indonesia and Vietnam are enlisting strategic MOUs to advance standard protocols. This shift is resulting in a structural outcome where Europe is reaching a reliance on AI Strategic Roadmaps and national digitization mandates to reach 2026 healthcare targets.

List of Companies

• Wolters Kluwer N.V.

• Becton, Dickinson and Company (BD)

• Premier, Inc.

• Inovalon, Inc.

• International Business Machines Corporation (IBM)

• Oracle Health (Cerner)

• Baxter International Inc.

• RLDatix Ltd.

• bioMérieux SA

• Roper Technologies, Inc.

Company Profiles

• Wolters Kluwer N.V.: Strategically distinct for its clinical decision support, the company is successfully enlisting AI medical information solutions that prioritize transparency and "Value beyond speed".

• Becton, Dickinson and Company (BD): Notable for its integrated diagnostics, the company is currently enlisting its BD Synapsys platform and new antimicrobial irrigation to build a comprehensive safety ecosystem.

• Baxter International Inc.: Distinguished by its recent combination with Hillrom, the company is successfully enlisting shared patient-centric cultures to enable care efficiencies across the hospital and home.

Analyst View

The global infection surveillance market is entering an "AI-Intercept" phase. Success for participants now depends on successfully enlisting interoperable cloud platforms and predictive analytics to satisfy 2026 national digitization mandates and patient safety targets through 2031.

Global Infection Surveillance Solution Market Scope: